PRESS RELEASE
News
-
NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
-
Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
-
Solitario CEO to Present at John Tumazos Very Independent Research, LLC
-
Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
-
GameSquare to Present at Upcoming Investor Conferences
-
Director/PDMR Shareholding
-
init is entering the market for the management of autonomous fleets through a stake in successful Norwegian start-up
-
2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of September 30, 2026
-
BILENDI: Bilendi unveils major evolution for BARI AI in its Bilendi Discuss platform
-
Amprion successfully issues more green bonds worth EUR 1.5 billion
